Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alloin
2. Aloin A
3. Aloin B
1. Aloin B
2. 28371-16-6
3. Isobarbaloin
4. 69vib0j2wk
5. Chembl3617994
6. Aloin A
7. 8015-61-0
8. 10r-beta-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone
9. (1s)-1,5-anhydro-1-[(9r)-4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9,10-dihydroanthracen-9-yl]-d-glucitol
10. 5133-19-7
11. Aloin (mixture Of A And B)
12. Unii-69vib0j2wk
13. Aloin, From Curacao Aloe, ~50%
14. Ncgc00183867-01
15. Barbaloin B
16. Aloin B; Isobarbaloin
17. Aloin B [mi]
18. Schembl181616
19. Chebi:74131
20. Dtxsid70904581
21. 9(10h)-anthracenone, 10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10s)-
22. Hy-n0886
23. Zinc4214775
24. Bdbm50120492
25. Mfcd00869345
26. Akos026749813
27. Cs-3708
28. Gs-6457
29. 9(10h)-anthracenone, 10-beta-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (r)-
30. Ncgc00389730-01
31. (10r)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10h-anthracen-9-one
32. Ac-34434
33. Ft-0655437
34. N1913
35. C17778
36. H12077
37. A901212
38. A916079
39. W-202188
40. Q27144440
41. 1,8-dihydroxy-10-(ss-d-glucopyranosyl)-3-(hydroxymethyl)-9(10h)-anthracenone
42. 10-ss-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone
43. 9(10h)-anthracenone,10-b-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-,(10r)-
44. (10r)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9,10-dihydroanthracen-9-one
45. (10r)-10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10h)-anthracenone
46. 9(10h)-anthracenone, 10-.beta.-d-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-, (10r)-
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C21H22O9 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 418.12638228 g/mol |
| Monoisotopic Mass | 418.12638228 g/mol |
| Topological Polar Surface Area | 168 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 630 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Cathartics
Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)
ABOUT THIS PAGE
A Aloin B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aloin B, including repackagers and relabelers. The FDA regulates Aloin B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aloin B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aloin B supplier is an individual or a company that provides Aloin B active pharmaceutical ingredient (API) or Aloin B finished formulations upon request. The Aloin B suppliers may include Aloin B API manufacturers, exporters, distributors and traders.
Aloin B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aloin B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aloin B GMP manufacturer or Aloin B GMP API supplier for your needs.
A Aloin B CoA (Certificate of Analysis) is a formal document that attests to Aloin B's compliance with Aloin B specifications and serves as a tool for batch-level quality control.
Aloin B CoA mostly includes findings from lab analyses of a specific batch. For each Aloin B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aloin B may be tested according to a variety of international standards, such as European Pharmacopoeia (Aloin B EP), Aloin B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aloin B USP).
LOOKING FOR A SUPPLIER?
